Bain Capital Life Sciences Investors, LLC Annexon, Inc. Transaction History
Bain Capital Life Sciences Investors, LLC
- $298 Million
- Q1 2025
A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 5,249,069 shares of ANNX stock, worth $12.6 Million. This represents 3.4% of its overall portfolio holdings.
Number of Shares
5,249,069
Previous 5,249,069
-0.0%
Holding current value
$12.6 Million
Previous $26.9 Million
62.38%
% of portfolio
3.4%
Previous 7.27%
Shares
9 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
96.9MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$17.8 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$16.8 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$15.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.1 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$12.9 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $114M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...